Form 4: Beauty Health Director Doug Schillinger Receives Significant RSU Grant

Doug K. Schillinger, a Director at The Beauty Health Company, was granted 73,051 Restricted Stock Units (RSUs) on June 16, 2025, aligning his interests with shareholders.

Summary

• Doug K. Schillinger, a Director of The Beauty Health Company (SKIN), acquired 73,051 shares of Class A Common Stock through a grant of Restricted Stock Units (RSUs).
• The transaction occurred on June 16, 2025.
• Following this acquisition, Mr. Schillinger directly beneficially owns a total of 216,035 shares of Class A Common Stock.
• The RSUs are set to vest on the earlier of the one-year anniversary of the grant date or the date of the Company's 2026 Annual Meeting of Stockholders.
• Vesting is contingent upon Mr. Schillinger's continued service as a member of the Company's board of directors through the vesting date.

Sentiment

Score: 6

Explanation: The document reports a routine equity grant to a director, which is a positive for aligning interests but does not indicate significant new financial performance or strategic shifts. It's a neutral-to-slightly positive event.

Positives

• The grant of Restricted Stock Units to Director Doug K. Schillinger aligns his financial interests directly with those of the Company's shareholders, promoting long-term value creation.
• Equity compensation is a standard practice for retaining and incentivizing board members.

Future Outlook

The granted Restricted Stock Units are forward-looking, with vesting contingent on the director's continued service until the earlier of the one-year anniversary of the grant or the 2026 Annual Meeting of Stockholders.

Industry Context

This RSU grant is a routine form of equity compensation for directors in publicly traded companies across various industries, including the beauty and health sector, designed to align management and board interests with shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of director compensation is a common and widely accepted practice across industries, including consumer health and beauty, aligning with typical corporate governance standards for incentivizing long-term commitment and performance.
• The vesting schedule, tied to continued service and a future annual meeting, is also standard for such grants, comparable to practices at companies like Estée Lauder, L'Oréal, or Ulta Beauty, which often use similar equity-based incentives for their non-employee directors.

Corporate Governance

Related Party Transactions

• The RSU grant to Doug K. Schillinger, a director, constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with shareholders, potentially leading to decisions that enhance long-term shareholder value.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• The RSUs will vest on the earlier of the one-year anniversary of the grant (June 16, 2026) or the date of the 2026 Annual Meeting of Stockholders, provided the director continues his service.

Key Dates

Keywords

Beauty Health Co, SKIN, SEC Form 4, Restricted Stock Units, RSU, Equity Grant, Director Compensation, Insider Transaction, Corporate Governance